文献速递类风湿关节炎

共病负担预测类风湿关节炎患者缓解可能性更低且疾病复发可能性更高

Multimorbidity burden predicts lower likelihood of remission and higher likelihood of disease flare in patients with rheumatoid arthritis.
PubMed 文献 · RMD Open · 2025-08-05

在明尼苏达州奥姆斯特德县1999至2014年发病的659例类风湿关节炎患者中,共病及重度共病分别预测复发几率升高29%和26%,缓解几率降低34%和33%;社会脆弱指数每升高0.1(高于0.3时)预测缓解几率降低8%。

要点

  • 共病(≥2种慢性病)预测复发几率升高29%,重度共病(≥5种)预测升高26%。
  • 共病预测缓解几率降低34%,重度共病预测降低33%。
  • 社会脆弱指数每升高0.1(高于0.3时)预测缓解几率降低8%。

核心结论

  • 共病预测类风湿关节炎复发几率更高且缓解几率更低,不良健康社会决定因素负担预测缓解几率更低。

研究设计与样本

  • 研究纳入明尼苏达州奥姆斯特德县1999至2014年发病的659例成人类风湿关节炎患者,使用55种慢性病清单定义共病(≥2种)和重度共病(≥5种),以区域剥夺指数和社会脆弱指数作为不良健康社会决定因素负担的替代指标,采用混合效应模型分析。

主要发现

  • 共病预测复发几率升高29%(OR:1.29,95%CI:1.04至1.59),重度共病预测升高26%(OR:1.26,95%CI:1.03至1.53)。
  • 共病预测缓解几率降低34%(OR:0.66,95%CI:0.49至0.90),重度共病预测降低33%(OR:0.67,95%CI:0.51至0.90)。
  • 社会脆弱指数在高于0.3时每升高0.1预测缓解几率降低8%(OR:0.92,95%CI:0.85至0.99)。
  • 复发还与女性、吸烟、较年轻年龄和较短病程相关,与血清阳性无关;缓解还与男性、从不吸烟、较年长年龄和较长病程相关,与血清阳性无关。

临床怎么用

  • 作者认为这些发现有可能为疾病预后判断和临床医生干预提供信息。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To examine associations between multimorbidity, the social determinants of health (SDoHs) and rheumatoid arthritis (RA) flare and remission. METHODS: All patients aged ≥18 years in Olmsted County, Minnesota, with incident RA in 1999-2014 were identified. Using a list of 55 chronic medical conditions, multimorbidity was defined as the presence of ≥2 conditions and substantial multimorbidity as ≥5 conditions. The Area Deprivation Index and Social Vulnerability Index (SVI) were used as proxies for adverse SDoH burden. Flare and remission were defined using Outcome Measures in Rheumatoid Arthritis Clinical Trials definitions. Mixed effects models were used to assess associations between flare/remission and multimorbidity, adverse SDoH burden and other patient characteristics. RESULTS: This study included 659 patients with incident RA. Multimorbidity and substantial multimorbidity predicted 29% (OR:1.29, 95% CI:1.04 to 1.59) and 26% (OR:1.26, 95% CI:1.03 to 1.53) higher odds of flare, respectively. Both were associated with 34% (OR:0.66, 95% CI:0.49 to 0.90) and 33% (OR:0.67, 95% CI:0.51 to 0.90) lower odds of remission, respectively. SVI predicted 8% lower odds of remission for every 0.1 increase above 0.3 (OR:0.92, 95% CI:0.85 to 0.99). Flare was also associated with female sex, smoking, younger age and shorter disease duration, but not seropositivity. Remission was also associated with male sex, never smoking, older age and longer disease duration, but not seropositivity. CONCLUSIONS: Multimorbidity predicts higher odds of RA flare and lower odds of remission. Adverse SDoH burden predicts lower odds of remission. These findings have the potential to inform disease prognostication and clinician interventions.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Montes D, Myasoedova E, Kodishala C, et al. Multimorbidity burden predicts lower likelihood of remission and higher likelihood of disease flare in patients with rheumatoid arthritis. RMD Open. 2025. PMID: 40764086. doi:10.1136/rmdopen-2025-005577

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。